As of 2026-09-15, the EV/EBITDA ratio of VBI Vaccines Inc (VBIV) is -0.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VBIV's latest enterprise value is 0.01 mil USD. VBIV's TTM EBITDA according to its financial statements is -45.59 mil USD. Dividing these 2 quantities gives us the above VBIV EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 17.8x | 17.2x |
| Forward P/E multiples | 20.1x - 23.7x | 20.7x |
| Fair Price | (5,972.32) - (5,287.56) | (5,641.85) |
| Upside | -9146077.1% - -8097435.7% | -8639993.6% |
| Date | EV/EBITDA |